Food Safety Incidents

Lack of proof in quality control has been detected in Nutritional Supplements.

Written by SGS Digicomply Editorial Team | Feb 27, 2026 11:00:00 PM

Incident Report: Nutritional Supplements Quality Control Issue

On February 12, 2026, a significant food safety incident was reported concerning nutritional supplements originating from Brazil. The Brazilian Health Regulatory Agency, known as ANVISA, has identified a lack of proof in the quality control processes associated with these products. This raises serious concerns regarding the safety and efficacy of the supplements available to consumers.

Quality control is a critical aspect of food safety, particularly for dietary supplements, which are intended to enhance health and well-being. The absence of adequate quality assurance measures can lead to products that may not contain the ingredients listed on their labels or may include harmful substances. This incident highlights the importance of stringent regulatory oversight to ensure that all nutritional supplements meet safety standards and provide the promised health benefits.

Consumers are advised to exercise caution when purchasing nutritional supplements, especially those from regions where regulatory practices may be inconsistent. It is essential to look for products that have undergone rigorous testing and quality assurance to ensure their safety and effectiveness.

As the investigation continues, further updates will be provided to ensure that consumers are informed about the safety of nutritional supplements and any necessary actions that may need to be taken to protect public health.

  • Incident: Lack of proof in quality control has been detected in Nutritional Supplements.
  • Date: 2026-02-12
  • Product: Nutritional Supplements
  • Market: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Origin of issue: Brazil
  • Hazard: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Incident Category: Control
  • Source: Brazilian Health Regulatory Agency - ANVISA